Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zonnic mouthspray added to nicotine patch for smoking cessation
ACTRN12609000482268Phase 3Completed
- Sponsor
- Health Research Council of New Zealand
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of nicotine in nicotine dependence (2 arms), sponsored by Health Research Council of New Zealand. Primary endpoints: Post-cessation smoking abstinence at 12 months and Continuous smoking abstinence over 12 months. Started Mar 2010; status: completed.
02
Drugs
nicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on ACTRN12609000482268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000482268.